Document is current
Any future updates will be listed below
-
Authors
Fernandez-Camins, Berta
Vlacho, Bogdan
Rojo-López, Marina Idalia
Granado-Casas, Minerva
Gratacòs, Mònica
Ortega-Bravo, Marta
Cendros-Massioui, Maria
Palmieri, Flavio
Perera-LLuna, Alexandre
Franch-Nadal, Josep
Mauricio, Dídac
,
-
Funding
Funding for this research was provided by:
Departament de Salut, Generalitat de Catalunya (SLT021/21/000030)
Instituto de Salud Carlos III (FIS PI21/01163)
Menarini Group
- License Information
-
More Information
Article History
Received: 17 March 2026
Accepted: 15 April 2026
First Online: 4 May 2026
Declarations
:
: The present study complies with all the ethical requirements and with the protection of the participant subjects as it complies with the legal ethical Spanish regulation (Real Decreto 957/2020 and the Biomedical Investigation Law 14/2007, 3 July) and the Declaration of Helsinki in its last revision. This protocol was evaluated by the Ethics Committee (CEI) before the inclusion of the patients (Hospital de la Santa Creu i Sant Pau Ethics Committee, ref. HSCSP 21/369 (OBS) dated 17 July 2021.; Ethics Committee for drug research (CEIm) at IDIAP Jordi Gol, CEIm ref. 21/266-P dated 15 December 2021; University Hospital of Bellvitge Ethics Committee for Research, ref. PR438/21 (CSI 21/86) dated 09 February 2022). The study protocol was registered on ClinicalTrials.gov with Trial Registration Number NCT05333718.
: Not applicable.
: The authors declare no competing interests.
